1 / 3

Japan Prazosin Market Size, Share & Forecast to 2026

Japan prazosin market is estimated to decline at a CAGR of around -2.6% during the forecast period. Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Minipress in Japan and is used for the treatment of various diseases including BPH, heart failure, high blood pressure, and Raynaud's syndrome. According to the American Heart Association in 2018, 43 million people in Japan were hypertensive, of which only 50% are treated, and about 25% are controlled at the target blood pressure (BP) level of <140/90 mm?Hg. The large number of hypertensive populations coupled with its poor control rate; hypertension is one of the leading causes of mortality in the country.

larebomrglobal
Download Presentation

Japan Prazosin Market Size, Share & Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Japan Prazosin Market:Industry Growth, Size, Share and Forecast 2020-2026 Request a Free Sample of Report Japan Prazosin Market https://www.omrglobal.com/request- sample/japan-prazosin-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040

  2. Japan prazosin market is estimated to decline at a CAGR of around -2.6% during the forecast period. Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Minipress in Japan and is used for the treatment of various diseases including BPH, heart failure, high blood pressure, and Raynaud's syndrome. According to the American Heart Association in 2018, 43 million people in Japan were hypertensive, of which only 50% are treated, and about 25% are controlled at the target blood pressure (BP) level of <140/90 mm?Hg. The large number of hypertensive populations coupled with its poor control rate; hypertension is one of the leading causes of mortality in the country. In addition, in July 2019, the two companies announced a definitive agreement for combining Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company. A full Report of Japan Prazosin Market at https://www.omrglobal.com/industry-reports/japan-prazosin- market The Report Covers Comprehensive research methodology of the Japan prazosin market. This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the Japan prazosin market. Insights about market determinants which are stimulating the Japan prazosin market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/japan-prazosin-market Japan Prazosin Market Segmentation By Application Cardiovascular Disease( CVD) Neurological Syndromes Prostate Disorders Kidney Disorders Company Profiles Ajinomoto Co., Inc. Johnlee Pharmaceuticals Pvt. Ltd. Merck KGaA

  3. Pfizer Inc. R&D Systems Inc. Renata Ltd. Mylan N.V. Standard Chem and Pharmaceuticals Co. Ltd. Sun Pharmaceuticals Industries Ltd. Teva Pharmaceuticals Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/japan-prazosin-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related